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Abstract
Aims To assess whether disturbances in glucose regulation are associated with impairment in physical performance during 
a 10-year follow-up.
Methods  475 Men and 603 women from the Helsinki Birth Cohort Study were studied. Glucose regulation was evaluated 
with a 2-h 75-g oral glucose tolerance test (OGTT) in 2001–2004. Subjects were categorised as having either impaired 
fasting glucose (IFG), impaired glucose tolerance (IGT), newly diagnosed diabetes or previously known diabetes. Physical 
performance was assessed approximately 10 years later using the validated senior fitness test (SFT). The relationship between 
glucose regulation and the overall SFT score was estimated using multiple linear regression models.
Results The mean age was 70.8 years for men and 71.0 years for women when physical performance was assessed. The mean 
SFT score for the whole population was 45.0 (SD 17.5) points. The SFT score decreased gradually with increased impair-
ment in glucose regulation. Individuals with previously known diabetes had the lowest overall SFT score in the fully adjusted 
model (mean difference compared to normoglycaemic individuals − 11.56 points, 95% CI − 16.15 to − 6.98, p < 0.001). 
Both individuals with newly diagnosed diabetes and individuals with IGT had significantly poorer physical performance 
compared to those with normoglycaemia. No significant difference in physical performance was found between those with 
IFG and those with normoglycaemia.
Conclusions Among older people, impaired glucose regulation is strongly related with poor physical performance. More 
severe disturbances in glucose regulation are associated with a greater decrease in physical function, indicating the impor-
tance of diagnosing these disturbances at an early stage.
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Introduction
The global burden of diabetes among older people is grow-
ing. The age-standardised prevalence of diabetes has dou-
bled since 1980 [1] and in the year 2017 globally over 
120 million people aged 65 years or older had diabetes 
[2]. In Finland in 2005, approximately 20% of adults over 
65 years were diagnosed with diabetes, whereas 30% of the 
older population had prediabetes, consisting of impaired 
glucose tolerance (IGT) or impaired fasting glucose (IFG) 
or a combination of the two [3]. The prevalence of diabetes 
and prediabetes in Finland is similar to the prevalence in 
other European countries [2]. Prediabetes has an annual 
risk of 5–10% of progressing to diabetes [4] and it also 
increases the risk for microvascular complications tradi-
tionally associated with diabetes [5, 6]. As the population 
ages due to increased life expectancy and a fall in fertil-
ity, non-communicable diseases such as heart disease and 
diabetes will become even more important causes of mor-
bidity and mortality, regardless of income level [7]. This 
calls for effective primary and secondary interventions in 
older people to reduce the disease burden and health care 
costs [8].
Decreased physical performance, an important predic-
tor of disability and functional decline, has been shown to 
have negative consequences on the daily life of older peo-
ple [9–11]. Diabetes is one of the major causes of physical 
limitation and individuals with diabetes have approximately 
50–80% greater risk of disability compared to those with-
out diabetes [12]. Age-related sarcopenia, characterised by 
loss of muscle strength and muscle quality, is accelerated by 
diabetes especially in the lower extremities [13, 14]. This 
increases the prevalence of mobility limitation and frailty 
at an earlier age, which reduces quality of life and results in 
loss of independence and institutionalisation [15, 16]. Dis-
ability and poor physical performance also lead to a rise in 
health care costs and an increased mortality rate [17, 18].
Although there is an apparent correlation between dia-
betes and physical disability, most studies focusing on 
this subject have been cross-sectional [12, 19, 20]. On the 
other hand, longitudinal studies have often relied on self-
reported diagnosis of diabetes or self-reported physical 
performance, mainly focusing on activities of daily living 
(ADL), instrumental activities of daily living (IADL) and 
motility [21–23]. Furthermore, there are no longitudinal 
studies assessing the relationship between prediabetes and 
physical performance.
To address this question, we studied the association 
between glucose regulation at an average age of 61 years and 
the objectively measured physical performance evaluated 
with the Senior Fitness Test (SFT) approximately 10 years 
later using data from the Helsinki Birth Cohort Study.
Materials and methods
Study population
The Helsinki Birth Cohort Study (HBCS) includes 13,345 
individuals born between 1934 and 1944 at the Helsinki 
University Central Hospital or the Helsinki City Maternity 
Hospital [24]. All subjects included in this study cohort 
attended child welfare clinics in Helsinki and were still liv-
ing in Finland in 1971, when all Finnish residents received 
a personal identification number [25]. A random sample 
of 2902 from those 8760 individuals who were born at 
the Helsinki University Central Hospital was invited to 
a baseline clinical examination in the year 2000. A total 
of 2003 cohort members participated in an examination 
conducted between 2001 and 2004. In 2011, members of 
the clinical cohort still alive and living within a 100-km 
radius of Helsinki were invited to participate in a clinical 
follow-up examination. A total of 1094 subjects partici-
pated in this clinical examination between 2011 and 2013. 
The cohort members that participated only in the baseline 
examination (n = 925) were older, more frequently men 
and smokers and they had higher BMI (all p < 0.028) com-
pared to those who were included in our study. The main 
reasons for declining invitation to the follow-up examina-
tion were related to personal or a family member’s health 
conditions. This study includes the 1078 subjects who had 
adequate information on physical performance and glu-
cose regulation [26]. The study was approved by the Eth-
ics Committee of Epidemiology and Public Health of the 
Hospital District of Helsinki and Uusimaa and that of the 
National Public Health Institute, Helsinki and follows the 
guidelines of the Declaration of Helsinki. All participants 
gave a written, informed consent.
Glucose regulation
Fasting plasma glucose was measured in all subjects at the 
baseline clinical examination in 2001 to 2004. A standard 
2-h 75-g oral glucose tolerance test (OGTT) was conducted 
in all individuals, except for those with previously known 
type 1 or type 2 diabetes (n = 50), defined by self-report, 
medical records or use of medication for diabetes. The 
World Health Organization 1999 criteria [27] were used 
for diagnosing diabetes, IGT, and IFG. Subjects reporting 
a diagnosis of diabetes or taking medications for diabetes 
before the clinical examination were classified as having 
previously known diabetes. Those diagnosed with type 2 
diabetes for the first time at the OGTT were classified as 
having newly diagnosed diabetes. Subjects meeting the cri-
teria for both IGT and IFG were categorised as having IGT.
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Physical performance
Subjects in the clinical follow-up were assessed for physical 
performance with the validated Senior Fitness Test (SFT) 
[28, 29]. A modified test battery consisting of five tests was 
carried out: (1) 30-s chair stand: number of full stands com-
pleted in 30 s with arms folded across chest to assess lower 
body strength, (2) Arm curl: number of bicep curls recorded 
in 30 s holding hand weight (3 kg for men and 2 kg for 
women) to assess upper body strength, (3) Back scratch: 
with one hand reaching over shoulder and the other one 
up middle back, number of centimetres between extended 
middle fingers to assess upper body (shoulder) flexibility, 
(4) Chair sit-and-reach: sitting at the front of chair with leg 
extended, number of centimetres between extended fingers 
and tip of toe to assess lower body (hamstring) flexibil-
ity, (5) 6 min walk: number of meters walked in 6 min to 
assess aerobic endurance. Measurements were performed by 
trained research assistants [26]. Subjects were rated for each 
test using percentile tables of normative data for 5-year age 
groups [29]. The rating varied between 1 and 20, based on 
5-‰ ranges, with 1 indicating a test result below the fifth 
percentile and 20 indicating a test result in the top 5 ‰. 
Finally, the overall score was calculated as the sum of the 
normalised ratings for all five SFT items. The overall score 
varied between 5 and 100.
Covariates
Questionnaires were used at the baseline clinical examina-
tion to assess current health situation, use of medication, 
educational attainment and lifestyle characteristics. Anthro-
pometric measurements including height, weight and waist 
circumference were measured. Body mass index (kg/m2) 
was calculated, and lean body mass and fat percentage were 
estimated with bioelectrical impedance using the InBody 
3.0 eight polar tactile electrode system (Biospace Co., Ltd., 
Seoul, Korea). Physical activity was assessed using a vali-
dated exercise questionnaire; the Kuopio Ischaemic Heart 
Disease Risk Factor Study (KIHD) 12-month leisure time 
physical activity (LTPA) history [30]. The questionnaire 
assigned a metabolic equivalent of task (MET) value for 
each specific activity and intensity. Physical activity is pre-
sented as MET-hours per day based on a 12-month history.
Statistical analysis
Means and standard deviations or medians and interquartile 
ranges were calculated for continuous variables, whereas 
categorical variables are presented as frequencies and pro-
portions. The associations between the characteristics of the 
cohort members and physical performance were assessed 
using linear regression analyses. Multiple linear regression 
models were used to assess the association between glucose 
regulation and physical performance. The results are pre-
sented pooled by sex, as none of the interactions for sex and 
the glucose regulation variables on the Senior Fitness Test 
were statistically significant (all p values > 0.52). In model 
1, we adjusted for sex and age. Next, we added adult socio-
economic status, smoking status, alcohol consumption and 
physical activity to model 2. In model 3, we further adjusted 
for body fat percentage. All tests were performed two-tailed 
and the level of significance was set at p < 0.05. Statistical 
analyses were carried out using IBM SPSS Statistics Version 
24 (IBM Corp., Armonk, NY, USA).
Results
A total of 475 men and 603 women were included in the 
analysis (Table 1). The mean age at the baseline clinical 
examination was 61.2 (SD 2.6) years for men and 61.3 
(SD 2.9) years for women. The prevalence of previously 
known diabetes was 6.7% for men and 3.0% for women. 
At the OGTT, 9.7% of the men and 5.1% of the women 
were diagnosed with new diabetes. Prediabetes had a higher 
prevalence, with 30.1% of the men and 29.2% of the women 
diagnosed with either IGT or IFG. The mean follow-up time 
between the OGTT and the SFT was 9.7 (SD 0.9) years for 
the entire cohort. Men had a mean age of 70.8 (SD 2.6) years 
and women a mean age of 71.0 (SD 2.8) years when physical 
performance was assessed.
The mean overall SFT score was 45.0 (SD 17.5) points for 
the entire cohort. Women had a 4.40 point (p < 0.001) higher 
SFT score compared to men (Table 2). Baseline lean body 
mass and body fat percentage showed a significant inverse 
association with the SFT score. Subjects with previously 
known diabetes at baseline had a 17.77 lower mean SFT 
score (p < 0.001) compared to subjects with normoglycae-
mia. Those with newly diagnosed diabetes (p < 0.001) and 
IGT (p < 0.001) also had a significantly lower SFT score 
compared to their normoglycaemic counterparts. There was 
no significant difference in SFT score between those with 
IFG and those with normoglycaemia (p = 0.26).
Table 3 shows the association between glucose regula-
tion and physical performance 10 years later. There was no 
significant difference in physical performance between sub-
jects with IFG and subjects with normoglycaemia. Those 
with previously known diabetes, newly diagnosed diabetes 
and IGT all had a lower SFT score compared to those with 
normoglycaemia. There was a graded increase in the inverse 
association between more severe impairment in glucose 
regulation and physical performance, as subjects with IGT 
showed the weakest association and subjects with previously 
known diabetes showed the strongest inverse association 
with the overall SFT score. After adjusting for sex, age, adult 
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socioeconomic status, and lifestyle factors, the regression 
coefficients were only slightly attenuated. However, further 
adjustment for body fat percentage had an impact on these 
associations. In the fully adjusted model, the mean differ-
ence in SFT score between subjects with previously known 
diabetes and normoglycaemic subjects was − 11.56 points 
(95% CI − 16.15 to − 6.98, p < 0.001).
The association between glucose regulation and the age 
standardised scores for the individual SFT tasks are pre-
sented in Table 4. In the fully adjusted model, subjects 
with previously known diabetes performed poorer in all 
tasks except the chair sit-and-reach test compared to those 
with normoglycaemia. The greatest difference between 
subjects with previously known diabetes and subjects with 
Table 1  Baseline characteristics 
for men and women in the 
Helsinki birth cohort study
a LTPA leisure time physical activity, values are given as median and interquartile ranges. MET metabolic 
equivalent of task, IFG impaired fasting glucose, IGT impaired glucose tolerance, Newly Diagnosed Dia-
betes: Diabetes diagnosed with oral glucose tolerance test at clinical examination during 2001–2004, Previ-
ously Known Diabetes: Diabetes diagnosed before clinical examination in 2001–2004
Variable Men (n = 475) Women (n = 603)
Mean SD Mean SD
Age at baseline (years) 61.2 2.6 61.3 2.9
Weight (kg) 85.5 12.2 72.4 12.7
Height (cm) 177.2 5.9 163.4 5.7
BMI (kg/m2) 27.2 3.5 27.1 4.6
Lean body mass (kg) 65.5 7.3 47.6 5.3
Body fat (percentage) 22.9 5.5 33.2 6.6
Fat mass (kg) 19.9 7.1 24.6 8.9
Waist circumference (cm) 99.6 10.3 89.3 11.7
Smoking status (r/n, %)
 Never smoked 134/474 28.3 344/603 57.0
 Ex-smoker 228/474 48.1 154/603 25.5
 Smoker 112/474 23.6 105/603 17.4
Alcohol consumption (r/n, %)
 Never used/ex-user 29/471 6.2 28/600 4.7
 Less than 1 day a week 126/471 26.8 311/600 51.8
 Weekly 316/471 67.1 261/600 43.5
Adult socioeconomic status (r/n, %)
 Labourer 186/475 39.2 123/603 20.4
 Lower middle 133/475 28.0 363/603 60.2
 Upper middle 112/475 23.6 69/603 11.4
 Self-employed 44/475 9.3 48/603 8.0
Self-reported physical activity (r/n, %)
 Sedentary 35/473 7.4 81/602 13.5
 1–2 times/week 227/473 48.0 264/602 43.9
 At least 3 times/week 211/473 44.6 257/602 42.7
LTPA (MET-h/Day)a 5.2 3.0 to 9.0 4.9 2.8 to 8.2
Education level (r/n, %)
 Basic 116/475 24.4 230/603 38.1
 Upper secondary 115/475 24.2 157/603 26.0
 Lower tertiary 143/475 30.1 159/603 26.4
 Upper tertiary 101/475 21.3 57/603 9.5
Glucose regulation (r/n, %)
 Normoglycaemic 254/475 53.5 378/603 62.7
 IFG 45/475 9.5 29/603 4.8
 IGT 98/475 20.6 147/603 24.4
 Newly diagnosed diabetes 46/475 9.7 31/603 5.1
 Previously known diabetes 32/475 6.7 18/603 3.0
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normoglycaemia was in the 6-min walk test (mean difference 
− 3.38, 95% CI − 4.76 to − 2.00, p < 0.001). Subjects with 
newly diagnosed diabetes performed significantly poorer in 
both the arm curl test and the back scratch test. Subjects with 
IGT performed poorer in the arm curl test, but there was no 
difference in the rest of the individual SFT tasks compared 
to subjects with normoglycaemia.
Discussion
In this study of community dwelling older people, we found 
that impaired glucose regulation was strongly associated 
with decreased physical performance nearly 10 years later. 
We showed that physical performance was poorer not only 
among individuals with diabetes, but also among those with 
IGT, even after controlling for confounding factors. There 
was a gradual decline in physical performance when transi-
tioning to more severe disturbances in glucose regulation, 
with subjects previously diagnosed with diabetes having the 
poorest physical performance. To the best of our knowledge, 
we are the first to report this kind of relationship between 
glucose regulation and physical performance in a longitu-
dinal study setting.
We confirmed the results from previous studies, sug-
gesting an association between diabetes and decreased 
physical performance. We found that after controlling for 
confounders, subjects with previously diagnosed diabetes 
had approximately 0.7 SD lower SFT score compared to 
subjects with normoglycaemia. In a meta-analysis by Wong 
and colleagues [12] including 26 studies, diabetes was 
shown to increase the risk of mobility disability, IADL dis-
ability and ADL disability. In a 7-year follow-up study of 
Mexican-Americans, diabetes was associated with roughly 
a 1.5–2 times greater risk of lower body disability compared 
to normoglycaemia [31]. Some data, although limited, are 
also available on the relationship between IGT and physical 
performance. In a cross-sectional study of 1391 individuals, 
both IGT and diabetes increased the risk of poor physical 
performance [32]. These results together with our findings 
suggest that physical performance is affected already at the 
stage of IGT.
Table 2  Associations (univariate) between subject characteristics and 
SFT score
SFT senior fitness test, b regression coefficient (unstandardised), 
LTPA leisure time physical activity, MET metabolic equivalent of 
task, IFG impaired fasting glucose, IGT impaired glucose tolerance
Variable N = 1078
b 95% CI p
Age at senior fitness test 
(years)
− 0.09 − 0.48 to 0.29 0.64
Sex
 Men Ref – –
 Women 4.40 2.23 to 6.49 < 0.001
Height (cm) − 0.10 − 0.21 to 0.02 0.11
Lean body mass (kg) − 0.27 − 0.36 to − 0.17 < 0.001
Body fat (%) − 0.51 − 0.64 to − 0.38 < 0.001
Smoking status
 Never smoked Ref – –
 Ex-smoker − 1.00 − 3.31 to 1.32 0.40
 Smoker − 9.18 − 11.93 to − 6.42 < 0.001
Alcohol consumption
 Never used/ex-user Ref – –
 Less than 1 day a week 4.68 − 0.13 to 9.50 0.06
 Weekly 5.92 1.17 to 10.66 0.02
Adult socioeconomic status
 Labourer Ref – –
 Lower middle 5.68 3.22 to 8.14 < 0.001
 Upper middle 7.52 4.34 to 10.70 < 0.001
 Self-employed 5.90 1.88 to 9.93 0.004
LTPA (MET-h/day) 0.15 − 0.05 to 0.35 0.14
Glucose regulation
 Normoglycaemic Ref – –
 IFG − 2.37 − 6.47 to 1.74 0.26
 IGT − 5.15 − 7.65 to − 2.65 < 0.001
 Newly diagnosed diabetes − 10.55 − 14.56 to − 6.54 < 0.001
 Previously known diabetes − 17.77 − 22.65 to − 12.90 < 0.001
Table 3  Regression coefficients for the association between glucose regulation and SFT score
a Normoglycaemia serves as the reference. Model 1: Adjusted for sex and age. Model 2: Further adjusted for adult socioeconomic status, smok-
ing status, alcohol consumption and physical activity. Model 3: Further adjusted for body fat percentage. SFT senior fitness test, b regression 
coefficient (unstandardised), IFG impaired fasting glucose, IGT impaired glucose tolerance
Glucose  regulationa Model 1 Model 2 Model 3
b 95% CI p b 95% CI p b 95% CI p
IFG − 1.69 − 5.80 to 2.42 0.42 − 2.03 − 6.04 to 1.98 0.32 0.47 − 3.47 to 4.40 0.82
IGT − 5.13 − 7.63 to − 2.63 < 0.001 − 5.31 − 7.77 to − 2.86 < 0.001 − 2.56 − 4.96 to − 0.16 0.04
Newly diagnosed diabetes − 9.86 − 13.87 to − 5.84 < 0.001 − 8.97 − 12.89 to − 5.05 < 0.001 − 5.49 − 9.26 to − 1.72 0.004
Previously known diabetes − 16.95 − 21.84 to − 12.07 < 0.001 − 15.72 − 20.54 to − 10.91 < 0.001 − 11.56 − 16.15 to − 6.98 < 0.001
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Several mechanisms may explain the association between 
impaired glucose regulation and decreased physical perfor-
mance. Insulin resistance has been shown to cause increased 
protein degradation and decreased protein synthesis in skel-
etal muscle. In the long term, this may cause loss of mus-
cle mass, which further aggravates glucose regulation, as 
skeletal muscle is important for the uptake of glucose [33]. 
Inflammatory markers associated with insulin resistance and 
obesity, such as interleukin-6 and C-reactive protein (CRP), 
may also contribute to functional decline by causing nega-
tive changes in the regulation of skeletal muscle homeostasis 
[16]. In addition, physical inactivity, mitochondrial dysfunc-
tion, decreased skeletal muscle blood flow and hyperglycae-
mia itself may explain the excess disability among adults 
with abnormal glucose regulation [34].
In our analysis, adjusting for body fat percentage weak-
ened the association between glucose regulation and physi-
cal performance. Body fat percentage and obesity are 
strongly associated with disturbances in glucose regulation 
and have been shown to be important predictors of poor 
physical performance [26, 35]. Excess body fat triggers low-
grade systemic inflammation and may cause accumulation 
of both intermuscular and intramuscular fat deposits [36]. 
This has been shown to have a negative impact on muscle 
strength and increase the risk of mobility disability [34]. 
Additionally, ectopic fat also affects glucose metabolism and 
it is suggested that this could be one of the triggers of insulin 
resistance [33]. Functional decline and physical inactivity, 
on the other hand, further increases the risk of obesity, meta-
bolic syndrome and other chronic diseases [37].
Compared to subjects with normoglycaemia, we found 
that people with previously known diabetes had, besides the 
lowest overall SFT score, also a poorer result on most SFT 
test components. This suggests that over time, many differ-
ent elements of physical performance important in daily life 
are affected among those with diabetes, including strength, 
endurance and flexibility. Previously known diabetes had 
the strongest inverse association with the 6-min walk test, 
indicating that lower body function in particular is decreased 
among individuals with diabetes. Newly diagnosed diabe-
tes, on the other hand, was inversely associated with only 
two out of five performance tests. This indicates that longer 
duration of diabetes is an important risk factor of decreased 
physical function [9, 13].
From a public health point of view, our results show opti-
mistic possibilities for potentially slowing down functional 
decline among older people. By diagnosing impairments 
in glucose regulation at an early stage, lifestyle interven-
tions and patient education might prevent further decline in 
glucose regulation [5], thereby promoting the maintenance 
of physical performance. This could ultimately lead to a 
reduction of health care costs and an increase in functional 
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as metformin, reduces the risk of progression to diabetes 
among subjects with prediabetes, however, this treatment 
has been shown to be less effective compared to lifestyle 
interventions [38]. A topic for future research would be to 
investigate if metformin could slow down the decline in 
physical performance among individuals with IGT.
This study has several strengths. We studied a large pop-
ulation which comprised both men and women. The long 
follow-up time of approximately 10 years enabled us to eval-
uate the long-term association between glucose regulation 
and physical performance. We used the OGTT to assess glu-
cose regulation and were thereby able to correctly classify 
subjects with a high sensitivity. Relying solely on fasting 
plasma glucose or  HbA1c when diagnosing diabetes has been 
shown to be less sensitive compared to using an OGTT, with 
nearly 50% of undiagnosed diabetes detected only with an 
OGTT [39]. Another strength is that we used the validated 
SFT to objectively measure physical performance among our 
subjects. Compared to testing single muscle groups, such as 
grip strength or gait speed, the SFT can be used to evaluate 
full-body physical performance, including strength, flex-
ibility and endurance. Another popular test of physical per-
formance, the Short Physical Performance Battery (SPPB), 
although effective in predicting disability, nursing home 
admittance and survival rates among older people, includes 
test components that have been shown to be either too easy 
or too difficult to perform [40].
This study also has some limitations. First, although we 
were able to adjust for several covariates, we did not adjust 
for complications associated with diabetes, including neu-
ropathy, retinopathy and peripheral vascular disease. These 
factors have been shown to be associated with disability and 
functional impairment among older people [35, 41]. In addi-
tion, there may be other unmeasured variables affecting our 
results. Second, physical performance was not assessed at 
the baseline clinical examination, thus, we were not able to 
report potential changes in physical performance during the 
follow-up time. This prevented us from addressing causality. 
The fact that individuals with the longest duration of diabe-
tes had the poorest physical performance suggests, however, 
that impaired glucose regulation causes a decline in physical 
performance over time. Third, we acknowledge the possibil-
ity of a selection bias, as only half of the subjects from the 
baseline clinical examination participated in the examination 
of physical performance. Fourth, we studied a homogenous 
population of Caucasians only living in a restricted area of 
Finland, and this should be taken into account when imple-
menting our findings in other populations.
In summary, there is a strong association between distur-
bances in glucose regulation and poor physical performance 
among older people. Decline in physical function is known 
to begin already at an early stage of impaired glucose regula-
tion, however, diabetes, and in particular, a long duration of 
diabetes further exacerbates this decline and affects several 
different aspects of physical performance among individuals 
with advanced age.
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